Firefly Neuroscience, Inc. (NASDAQ:AIFF) Sees Large Decline in Short Interest

Firefly Neuroscience, Inc. (NASDAQ:AIFF) was the recipient of a significant drop in short interest in September. As of September 30th, there was short interest totaling 884,200 shares, a drop of 37.3% from the September 15th total of 1,410,000 shares. Currently, 15.0% of the shares of the stock are sold short. Based on an average daily trading volume, of 2,040,000 shares, the short-interest ratio is currently 0.4 days. Based on an average daily trading volume, of 2,040,000 shares, the short-interest ratio is currently 0.4 days. Currently, 15.0% of the shares of the stock are sold short.

Firefly Neuroscience Price Performance

Shares of AIFF opened at $2.03 on Thursday. Firefly Neuroscience has a 1-year low of $1.86 and a 1-year high of $17.20. The stock has a market cap of $27.30 million, a PE ratio of -0.81 and a beta of 2.11. The firm has a 50-day simple moving average of $2.75 and a two-hundred day simple moving average of $2.95.

Firefly Neuroscience (NASDAQ:AIFF) last announced its quarterly earnings results on Wednesday, August 13th. The company reported ($0.14) earnings per share for the quarter. Firefly Neuroscience had a negative net margin of 5,335.75% and a negative return on equity of 464.02%.

Insider Buying and Selling at Firefly Neuroscience

In other news, major shareholder Windsor Private Capital Lp sold 78,031 shares of the firm’s stock in a transaction dated Wednesday, October 22nd. The shares were sold at an average price of $2.07, for a total value of $161,524.17. Following the transaction, the insider directly owned 1,236,773 shares of the company’s stock, valued at approximately $2,560,120.11. This trade represents a 5.93% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. Insiders have sold 400,000 shares of company stock valued at $1,015,775 over the last quarter. Company insiders own 6.44% of the company’s stock.

Institutional Investors Weigh In On Firefly Neuroscience

A hedge fund recently raised its stake in Firefly Neuroscience stock. Geode Capital Management LLC raised its stake in shares of Firefly Neuroscience, Inc. (NASDAQ:AIFF) by 92.9% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 120,604 shares of the company’s stock after acquiring an additional 58,067 shares during the period. Geode Capital Management LLC owned approximately 0.94% of Firefly Neuroscience worth $341,000 as of its most recent SEC filing. 4.96% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Firefly Neuroscience in a research note on Wednesday, October 8th. One research analyst has rated the stock with a Sell rating, According to MarketBeat.com, Firefly Neuroscience currently has an average rating of “Sell”.

About Firefly Neuroscience

Firefly Neuroscience, Inc, a medical technology and artificial intelligence company, provides neuroscientific solutions that improve outcomes for patients with mental illnesses and neurological disorders. The company offers Brain Network Analytics, a software that focuses on diagnostic and treatment for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder.